CHL: Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph
What it covers
A blood gases (PCO2, PO2) and blood pH test system is a device intended to measure certain gases in blood, serum, plasma or pH of blood, serum, and plasma. Measurements of blood gases (PCO2, PO2) and blood pH are used in the diagnosis and treatment of life-threatening acid-base disturbances.
The identification in 21 CFR 862.1120, blood gases (PCO2, PO2) and blood pH test system. FDA gives CHL no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K252207 | ABL90 FLEX PLUS System, safeCLINITUBES | Radiometer Medicals Aps | Apr 10, 2026 | Traditional |
| K244014 | i-STAT CG4+ cartridge with the i-STAT 1 System | Abbott Point of Care, Inc. | May 2, 2025 | Traditional |
| K240998 | ABL90 FLEX PLUS System | Radiometer Medicals Aps | Dec 13, 2024 | Traditional |
| K230285 | i-STAT CG8+ cartridge with the i-STAT 1 System | Abbott Point of Care, Inc. | Oct 27, 2023 | Traditional |
| K221900 | Stat Profile Prime Plus Analyzer System | Nova Biomedical Corporation | Sep 29, 2023 | Traditional |
| K223857 | i-STAT G3+ cartridge with the i-STAT 1 System | Abbott Point of Care, Inc. | Sep 15, 2023 | Traditional |
| K223608 | GEM Premier 7000 with IQM3 | Instrumentation Laboratory Company | Aug 10, 2023 | Traditional |
| K211559 | EasyStat 300 | Medica Corporation | Jan 27, 2023 | Traditional |
| K203790 | GEM Premier 5000 | Instrumentation Laboratory CO | Aug 20, 2021 | Special |
| K200986 | OPTI® B-Lac Cassette | Opti Medical Systems, Inc. | Aug 2, 2021 | Traditional |
Clearances by year
39 CHL 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2026 (so far) | 1 | 270 |
| 2025 | 1 | 127 |
| 2024 | 1 | 246 |
| 2023 | 5 | 267 |
| 2021 | 2 | 355 |
| 2020 | 4 | 100 |
| 2018 | 1 | 215 |
| 2017 | 1 | 59 |
| 2016 | 3 | 306 |
| 2015 | 4 | 155 |
| 2014 | 3 | 68 |
| 2013 | 5 | 152 |
| 2012 | 4 | 65 |
| 2011 | 4 | 108 |
Who submits
14 applicants cleared a CHL device since 2011. 64% of the clearances went to applicants in United States, then Denmark (31%), Canada (3%) and China (3%). By type: Traditional 64% and Special 36%.
| Applicant | Clearances since 2011 |
|---|---|
| Radiometer Medical Aps | 10 |
| Nova Biomedical Corporation | 8 |
| Abbott Point of Care, Inc. | 4 |
| Instrumentation Laboratory CO | 4 |
| Opti Medical Systems, Inc. | 3 |
| Radiometer Medicals Aps | 2 |
| Edan Instruments, Inc. | 1 |
| Epocal, Inc. | 1 |
How FDA classifies it
Class II.
From 21 CFR 862.1120.
Standards
21 CFR 862.1120 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent CHL clearances declared.
Ask about CHL
Questions about CHL
What is FDA product code CHL?
Product code CHL, “Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph” in FDA's classification database, is a Class II device type under 21 CFR 862.1120 (blood gases (PCO2, PO2) and blood pH test system), reviewed by FDA's Clinical Chemistry panel. FDA's 510(k) database lists 188 clearances under CHL, 39 of them since 2011.
How many 510(k) clearances are there under CHL?
FDA’s 510(k) database listed 188 clearances under CHL as of Oct 29, 2026, 39 of them decided since 2011; the most recent decision was Apr 10, 2026. The Predicate Finder searches the live database.
How long does FDA take to clear a CHL 510(k)?
For the 3 CHL clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 246 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most CHL clearances?
Since 2011: Radiometer Medical Aps (10), Nova Biomedical Corporation (8), Abbott Point of Care, Inc. (4), Instrumentation Laboratory CO (4) and Opti Medical Systems, Inc. (3). 14 applicants have cleared a CHL device in that time.